The Challenge

Despite improvements in primary immunosuppressive therapies, long-term survival after liver transplantation has not seen significant progress over the past four decades. The client faced challenges in accurately predicting long-term liver graft survival and optimizing donor-recipient compatibility. The existing Liver Donor Risk Index (LDRI) model did not accurately reflect post-transplant liver graft survival, nor did it account for recipient-specific factors.

Our Solution

Agilisium developed an advanced analytics solution leveraging AI/ML models designed to enhance donor-recipient mapping and improve graft survival rates. This solution focuses on the following key aspects:

1
Democratized Data Access
Developed a non-SQL method for querying data within the EDF, eliminating the need for SQL knowledge.

Exploratory Data Analysis (EDA)

Performed EDA on liver transplant data to identify the clinical variables that influence post-transplant liver graft survival.

2

Enhanced LDRI Model

Integrated both donor characteristics and recipient factors to provide a more accurate prediction model of liver graft outcomes.

3

Cytokine Profiling

Analyzed the effect of cytokine profiles in the Early Allograft Dysfunction (EAD) presentation, providing insights into the immune response post-transplant.

4

Ensemble Classifier Development

Developed an ensemble classifier to predict the relative risk of graft failure based on various clinical and molecular factors.

5
Key Impact
11%
Improvement in donor-recipient match prediction​
The customer
A prestigious U.S.-based research institution globally recognized for its pioneering work in translating discoveries into life-saving therapies.

The Outcomes

Accelerating R&D and Improving Patient Outcomes

Improved Predictive Accuracy

Enhances the accuracy of predicting liver graft survival, allowing for better donor-recipient matching.

Better Patient Outcomes

Reduces the risk of unsuccessful transplants, thereby improving the use of scarce liver grafts.

Comprehensive Reporting

Delivers detailed reports on model evaluation, validation, and cytokine impact, providing actionable insights for clinical decision-making.

Accelerated Research and Development

Aids in development of new transplant methodologies and improving patient care.

Similar Case Studies

Case study
Transforming datamanagement in a leadingpharmaceutical company withdata lens
Case study
Transforming data Transforming Biotech Field Operations: Enhancing Efficiency and Accuracy with Doc Sonar, a Gen Al-Driven Solution
Read more
Case study
Transforming datamanagement in a leadingpharmaceutical company withdata lens
Case study
Transforming data Transforming Biotech Field Operations: Enhancing Efficiency and Accuracy with Doc Sonar, a Gen Al-Driven Solution
Read more
Case study
Transforming datamanagement in a leadingpharmaceutical company withdata lens
Case study
Transforming data Transforming Biotech Field Operations: Enhancing Efficiency and Accuracy with Doc Sonar, a Gen Al-Driven Solution
Read more
Case study
Transforming datamanagement in a leadingpharmaceutical company withdata lens
Case study
Transforming data Transforming Biotech Field Operations: Enhancing Efficiency and Accuracy with Doc Sonar, a Gen Al-Driven Solution
Read more